{"id":"https://openalex.org/W7214977225","doi":"https://doi.org/10.3389/fneur.2026.1895857","title":"Cytokine-induced killer cells combined with temozolomide suppress glioblastoma progression in an orthotopic model and demonstrate clinical feasibility in recurrent glioblastoma","display_name":"Cytokine-induced killer cells combined with temozolomide suppress glioblastoma progression in an orthotopic model and demonstrate clinical feasibility in recurrent glioblastoma","publication_year":2026,"publication_date":"2026-09-30","ids":{"openalex":"https://openalex.org/W7214977225","doi":"https://doi.org/10.3389/fneur.2026.1895857","pmid":"https://pubmed.ncbi.nlm.nih.gov/42877257","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13662175"},"language":"en","primary_location":{"id":"doi:10.3389/fneur.2026.1895857","doi":"https://doi.org/10.3389/fneur.2026.1895857","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1895857","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1895857/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1895857/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153648862","display_name":"Young Kyu Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105394","display_name":"Konyang University Hospital","ror":"https://ror.org/01eksj726","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210105394"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Young Kyu Park","raw_affiliation_strings":["Department of Oncology-Hematology, Konyang University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology-Hematology, Konyang University Hospital","institution_ids":["https://openalex.org/I4210105394"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029060949","display_name":"Dong Won Yang","orcid":"https://orcid.org/0009-0002-5307-8971","observed_orcids":["https://orcid.org/0009-0002-5307-8971"]},"institutions":[{"id":"https://openalex.org/I165028127","display_name":"Konyang University","ror":"https://ror.org/02v8yp068","country_code":"KR","type":"education","lineage":["https://openalex.org/I165028127"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Dong Won Yang","raw_affiliation_strings":["Department of Biomedical Informatics, College of Medicine, Konyang University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Informatics, College of Medicine, Konyang University","institution_ids":["https://openalex.org/I165028127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153644633","display_name":"Kyun Woo Park","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyun Woo Park","raw_affiliation_strings":["Department of Medical Oncology, Yuseong Sun General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Yuseong Sun General Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153584927","display_name":"Gun He Nam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gun He Nam","raw_affiliation_strings":["Product Development Division, GC Cell Corp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development Division, GC Cell Corp","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077361068","display_name":"Choon-Soo Lee","orcid":"https://orcid.org/0000-0003-2618-2327","observed_orcids":["https://orcid.org/0000-0003-2618-2327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Choon-Soo Lee","raw_affiliation_strings":["Product Development Division, GC Cell Corp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Development Division, GC Cell Corp","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107846361","display_name":"Tae Whan Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210109629","display_name":"GC Corporation (Japan)","ror":"https://ror.org/01jrqwn31","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210109629"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tae Whan Kim","raw_affiliation_strings":["R&D M Unit, GC Cell Corp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D M Unit, GC Cell Corp","institution_ids":["https://openalex.org/I4210109629"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153579424","display_name":"Jong-Yeup Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165028127","display_name":"Konyang University","ror":"https://ror.org/02v8yp068","country_code":"KR","type":"education","lineage":["https://openalex.org/I165028127"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Jong-Yeup Kim","raw_affiliation_strings":["Department of Biomedical Informatics, College of Medicine, Konyang University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biomedical Informatics, College of Medicine, Konyang University","institution_ids":["https://openalex.org/I165028127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5153662037","display_name":"Jong Gwon Choi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105394","display_name":"Konyang University Hospital","ror":"https://ror.org/01eksj726","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210105394"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Jong Gwon Choi","raw_affiliation_strings":["Department of Oncology-Hematology, Konyang University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology-Hematology, Konyang University Hospital","institution_ids":["https://openalex.org/I4210105394"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5153579424","https://openalex.org/A5153662037"],"corresponding_institution_ids":["https://openalex.org/I165028127","https://openalex.org/I4210105394"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.70149895,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1895857","last_page":"1895857"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytokine-induced-killer-cells","display_name":"cytokine-induced killer cells","score":0.9200000166893005},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8949999809265137},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.8510000109672546},{"id":"https://openalex.org/keywords/dnam-1","display_name":"DNAM-1","score":1.0},{"id":"https://openalex.org/keywords/effector-memory-t-cells","display_name":"effector memory T cells","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.5040000081062317},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7509999871253967},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.4699999988079071}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.8855000138282776},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8258000016212463},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5461000204086304},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5418999791145325},{"id":"https://openalex.org/C2780380082","wikidata":"https://www.wikidata.org/wiki/Q12646460","display_name":"Granzyme B","level":4,"score":0.5139999985694885},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.48179998993873596},{"id":"https://openalex.org/C161997846","wikidata":"https://www.wikidata.org/wiki/Q4915066","display_name":"Bioluminescence imaging","level":5,"score":0.42910000681877136},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.4235999882221222},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.41519999504089355},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.376800000667572},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35740000009536743},{"id":"https://openalex.org/C2780964509","wikidata":"https://www.wikidata.org/wiki/Q416975","display_name":"Dacarbazine","level":3,"score":0.32339999079704285},{"id":"https://openalex.org/C102652120","wikidata":"https://www.wikidata.org/wiki/Q2419430","display_name":"Therapeutic effect","level":2,"score":0.3190000057220459},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3183000087738037},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.3163999915122986},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.31439998745918274},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3027999997138977},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.2939999997615814},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.28279998898506165},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2822999954223633},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.2802000045776367},{"id":"https://openalex.org/C2779130545","wikidata":"https://www.wikidata.org/wiki/Q233309","display_name":"Brain tumor","level":2,"score":0.2791999876499176},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2759000062942505},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.27570000290870667},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2554999887943268},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.25099998712539673}],"mesh":[{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000077204","descriptor_name":"Temozolomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055612","descriptor_name":"Cytokine-Induced Killer Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055612","descriptor_name":"Cytokine-Induced Killer Cells","qualifier_ui":"Q000637","qualifier_name":"transplantation","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fneur.2026.1895857","doi":"https://doi.org/10.3389/fneur.2026.1895857","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1895857","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1895857/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13662175","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13662175/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13662175/pdf/fneur-17-1895857.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Neurol","raw_type":"Text"},{"id":"pmid:42877257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42877257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in neurology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:80cf30b52d4e43638fb46b40b46c3ae8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/80cf30b52d4e43638fb46b40b46c3ae8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Neurology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fneur.2026.1895857","doi":"https://doi.org/10.3389/fneur.2026.1895857","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1895857","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1895857/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214977225.pdf","grobid_xml":"https://content.openalex.org/works/W7214977225.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1792532087","https://openalex.org/W1996242270","https://openalex.org/W2012171870","https://openalex.org/W2060029380","https://openalex.org/W2075732353","https://openalex.org/W2084112669","https://openalex.org/W2129113646","https://openalex.org/W2138872728","https://openalex.org/W2155140015","https://openalex.org/W2164524832","https://openalex.org/W2526477473","https://openalex.org/W2759177017","https://openalex.org/W2789346374","https://openalex.org/W2790035192","https://openalex.org/W2802536440","https://openalex.org/W2890494395","https://openalex.org/W2903614074","https://openalex.org/W2947899700","https://openalex.org/W3026551532","https://openalex.org/W3028618058","https://openalex.org/W3037920841","https://openalex.org/W4200516862","https://openalex.org/W4207070503","https://openalex.org/W4213222228","https://openalex.org/W4226309233","https://openalex.org/W4307746536","https://openalex.org/W4315926035","https://openalex.org/W4392779080","https://openalex.org/W4403432106"],"related_works":["https://openalex.org/W2327924711","https://openalex.org/W2129113646","https://openalex.org/W2609186776","https://openalex.org/W4226309233","https://openalex.org/W2526477473","https://openalex.org/W4406027814","https://openalex.org/W2104538013","https://openalex.org/W2608434100","https://openalex.org/W2012171870","https://openalex.org/W7165768966"],"abstract_inverted_index":{"Introduction":[0],"Glioblastoma":[1],"(GBM)":[2],"remains":[3],"an":[4,35,177],"aggressive":[5],"primary":[6],"brain":[7],"tumor":[8,182],"with":[9,24,46,80,98],"limited":[10],"therapeutic":[11,275],"options":[12],"after":[13],"recurrence.":[14],"Cytokine-induced":[15],"killer":[16],"(CIK)":[17],"cells":[18,270],"are":[19,282],"ex":[20],"vivo-expanded":[21],"cytotoxic":[22],"lymphocytes":[23],"T-cell":[25],"and":[26,40,66,83,88,110,113,140,150,161,192,220,244],"natural":[27],"killer-like":[28],"properties.":[29],"We":[30],"evaluated":[31,92],"CIK-cell-based":[32,227,250],"therapy":[33,228,251],"using":[34],"orthotopic":[36,61],"LN229-luciferase":[37],"GBM":[38],"model":[39],"a":[41,106,120,261],"retrospective":[42],"cohort":[43],"of":[44,240,249,267],"patients":[45,97],"recurrent":[47,99,253],"GBM.":[48,100,254],"Methods":[49],"Twelve":[50],"independently":[51],"manufactured":[52],"patient-derived":[53],"CIK-cell":[54,103],"products":[55,104],"were":[56,74,90],"phenotypically":[57],"characterized.":[58],"In":[59,199],"the":[60,125,200,206,246,256],"model,":[62],"control,":[63,147],"temozolomide":[64],"(TMZ),":[65],"TMZ+CIK":[67,141,151,162],"groups":[68,127],"(n":[69],"=":[70,133,171,187],"4":[71,130],"per":[72],"group)":[73],"monitored":[75],"by":[76],"longitudinal":[77],"bioluminescence":[78,117],"imaging,":[79],"quantitative":[81,237],"histological":[82],"immunohistochemical":[84],"analyses.":[85],"Clinical":[86],"outcomes":[87],"safety":[89],"retrospectively":[91],"in":[93,181,210,252],"12":[94],"heavily":[95],"pretreated":[96],"Results":[101],"Expanded":[102],"showed":[105,142,176],"predominant":[107],"effector-memory":[108],"phenotype":[109],"high":[111],"NKG2D":[112],"DNAM-1":[114],"expression.":[115],"Longitudinal":[116],"imaging":[118],"demonstrated":[119],"significant":[121,168,263],"treatment-by-time":[122],"interaction":[123],"among":[124],"three":[126],"through":[128,163],"Week":[129,136,164],"(":[131,169,185],"p":[132,170,186],"0.0054).":[134],"At":[135],"4,":[137],"both":[138],"TMZ":[139,149,160,272],"significantly":[143],"lower":[144],"radiance":[145],"than":[146],"whereas":[148,189],"did":[152,195],"not":[153,167,196,259],"differ":[154,197],"significantly.":[155,198],"An":[156],"exploratory":[157],"comparison":[158],"between":[159],"8":[165],"was":[166,205,217,224,229],"0.0663).":[172],"Quantitative":[173],"H&E":[174],"analysis":[175],"overall":[178,222],"group":[179],"difference":[180],"area":[183],"fraction":[184],"0.0376),":[188],"Granzyme":[190],"B":[191],"CD56":[193],"staining":[194],"clinical":[201,247,274],"cohort,":[202],"stable":[203],"disease":[204],"best":[207],"recorded":[208],"response":[209],"all":[211],"evaluable":[212],"patients;":[213],"median":[214,221],"progression-free":[215],"survival":[216,223],"10.5":[218],"months":[219],"14.2":[225],"months.":[226],"generally":[230],"well":[231],"tolerated.":[232],"Discussion":[233],"These":[234],"findings":[235],"provide":[236],"preclinical":[238,265],"evidence":[239],"treatment-associated":[241],"antitumor":[242],"activity":[243],"support":[245],"feasibility":[248],"However,":[255],"study":[257],"does":[258],"establish":[260],"statistically":[262],"incremental":[264],"benefit":[266],"adding":[268],"CIK":[269],"to":[271],"or":[273],"efficacy.":[276],"Prospective,":[277],"adequately":[278],"powered":[279],"controlled":[280],"studies":[281],"warranted.":[283]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-01T00:00:00"}